| Literature DB >> 20656380 |
Elsa Moreno1, Saioa Ancizu, Silvia Pérez-Silanes, Enrique Torres, Ignacio Aldana, Antonio Monge.
Abstract
As a continuation of our research and with the aim of obtaining new anti-tuberculosis agents which can improve the current chemotherapeutic anti-tuberculosis treatments, forty-three new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives were synthesized and evaluated for in vitro anti-tuberculosis activity against Mycobacterium tuberculosis strain H(37)Rv. Active compounds were also screened to assess toxicity to a VERO cell line. Results indicate that compounds with a methyl moiety substituted in position 3 and unsubstituted benzyl substituted on the carboxamide group provide an efficient approach for further development of anti-tuberculosis agents. Copyright (c) 2010 Elsevier Masson SAS. All rights reserved.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20656380 DOI: 10.1016/j.ejmech.2010.06.036
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514